• Cost-Effectiveness of Current and Emerging Treatments of Varicose Veins

    Aug 1, 2018, 00:00
  • Qualitative Research to Explore the Patient Experience of X-Linked Hypophosphatemia and Evaluate the Suitability of the BPI-SF and WOMAC® as Clinical Trial End Points

    Aug 1, 2018, 00:00
  • Surveying the Cost-Effectiveness of the 20 Procedures with the Largest Public Health Services Waiting Lists in Ireland- Implications for Ireland’s Cost-Effectiveness Threshold

    Aug 1, 2018, 00:00
  • Test-Retest Reliability of Discrete Choice Experiment for Valuations of QLU-C10D Health States

    Aug 1, 2018, 00:00
  • Table of Contents

    Aug 1, 2018, 00:00
  • Estimating Future Health Technology Diffusion Using Expert Beliefs Calibrated to an Established Diffusion Model

    Aug 1, 2018, 00:00
  • Health-Related Quality of Life in People Living with Psychotic Illness and Factors Associated with Its Variation

    Aug 1, 2018, 00:00
  • Productivity Benefits of Medical Care- Evidence from US-Based Randomized Clinical Trials

    Aug 1, 2018, 00:00
  • Advocating a Paradigm Shift in Health-State Valuations- The Estimation of Time-Preference Corrected QALY Tariffs

    Aug 1, 2018, 00:00
  • Initial Development and Content Validation of a Health-Related Symptom Index for Persons either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions

    Aug 1, 2018, 00:00
  • Copyright/Subscription

    Jul 30, 2018, 04:11
  • Copyright/Subscription

    Jul 29, 2018, 00:45
  • Copyright/Subscription

    Jul 28, 2018, 22:10
  • Copyright/Subscription

    Jul 28, 2018, 18:10
  • Author Index

    Jul 26, 2018, 19:32
  • Management Costs of the First Five Years After Diagnosis in Breast Cancer by Stage in France

    Jul 25, 2018, 22:22
  • Uncertainty and the Undervaluation of Services for Severe Health States in Cost-Utility Analyses

    Jul 1, 2018, 00:00
  • Heterogeneity and Uncertainties Specific to Genome-Based Health Technological Assessments

    Jul 1, 2018, 00:00
  • Can Social Care Needs and Well-Being Be Explained by the EQ-5D? Analysis of the Health Survey for England

    Jul 1, 2018, 00:00
  • CORRECTION

    Jul 1, 2018, 00:00
  • Time to Entry for New Cancer Medicines- From European Union–Wide Marketing Authorization to Patient Access in Belgium, Estonia, Scotland, and Sweden

    Jul 1, 2018, 00:00
  • Long-Term Health and Economic Value of Improved Mobility among Older Adults in the United States

    Jul 1, 2018, 00:00
  • Informing a priori Sample Size Estimation in Qualitative Concept Elicitation Interview Studies for Clinical Outcome Assessment Instrument Development

    Jul 1, 2018, 00:00
  • Table of Contents

    Jul 1, 2018, 00:00
  • Critical Analysis of Markov Models Used for the Economic Evaluation of Colorectal Cancer Screening- A Systematic Review

    Jul 1, 2018, 00:00
  • Value of External Data in the Extrapolation of Survival Data- A Study Using the NJR Data Set

    Jul 1, 2018, 00:00
  • Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries- Trends in Cost-per-DALY Studies

    Jul 1, 2018, 00:00
  • Best Methods of Communicating Clinical Trial Data to Improve Understanding of Treatments for Patients with Multiple Sclerosis

    Jul 1, 2018, 00:00
  • Cost-Effectiveness Analysis in Telehealth- A Comparison between Home Telemonitoring, Nurse Telephone Support, and Usual Care in Chronic Heart Failure Management

    Jul 1, 2018, 00:00
  • A multigene test could cost-effectively help extend life expectancy for women at risk of hereditary breast cancer—Reply to letter to the editor by Petelin et al.

    Jul 1, 2018, 00:00
  • Effect of Level Overlap and Color Coding on Attribute Non-Attendance in Discrete Choice Experiments

    Jul 1, 2018, 00:00
  • What Characteristics of Nursing Homes Are Most Valued by Consumers? A Discrete Choice Experiment with Residents and Family Members

    Jul 1, 2018, 00:00
  • Economic Burden of Cardiovascular Disease in Type 2 Diabetes- A Systematic Review

    Jul 1, 2018, 00:00
  • Editorial Board

    Jul 1, 2018, 00:00
  • Personalized Mammography Screening and Screening Adherence—A Simulation and Economic Evaluation

    Jul 1, 2018, 00:00
  • Copyright/Subscription

    Jul 1, 2018, 00:00
  • Instructions for Authors

    Jul 1, 2018, 00:00
  • Economic Evaluation of the Hepatitis C Virus Treatment Extension to Early-Stage Fibrosis Patients- Evidence from the PITER Real-World Cohort

    Jul 1, 2018, 00:00
  • Medical Treatments for Acromegaly- A Systematic Review and Network Meta-Analysis

    Jul 1, 2018, 00:00
  • Development of Methods for the Mapping of Utilities Using Mixture Models- Mapping the AQLQ-S to the EQ-5D-5L and the HUI3 in Patients with Asthma

    Jun 1, 2018, 00:00
  • Copyright/Subscription

    Jun 1, 2018, 00:00
  • A Modeling Study of the Cost-Effectiveness of a Risk-Stratified Surveillance Program for Melanoma in the United Kingdom

    Jun 1, 2018, 00:00
  • Core Items for a Standardized Resource Use Measure- Expert Delphi Consensus Survey

    Jun 1, 2018, 00:00
  • Editorial Board

    Jun 1, 2018, 00:00
  • Building Synergy between Regulatory and HTA Agencies beyond Processes and Procedures—Can We Effectively Align the Evidentiary Requirements? A Survey of Stakeholder Perceptions

    Jun 1, 2018, 00:00
  • State Medicaid Reimbursement for Medications for Chronic Hepatitis C Infection from 2012 through 2015

    Jun 1, 2018, 00:00
  • Effect of Crossover in Oncology Clinical Trials on Evidence Levels in Early Benefit Assessment in Germany

    Jun 1, 2018, 00:00
  • Selection of and Evidentiary Considerations for Wearable Devices and Their Measurements for Use in Regulatory Decision Making- Recommendations from the ePRO Consortium

    Jun 1, 2018, 00:00
  • Experiences of Structured Elicitation for Model-Based Cost-Effectiveness Analyses

    Jun 1, 2018, 00:00
  • Cost-Effectiveness Analysis of a Navigation Program for Colorectal Cancer Screening to Reduce Social Health Inequalities- A French Cluster Randomized Controlled Trial

    Jun 1, 2018, 00:00
  • Expert Elicitation of Multinomial Probabilities for Decision-Analytic Modeling- An Application to Rates of Disease Progression in Undiagnosed and Untreated Melanoma

    Jun 1, 2018, 00:00
  • Computer Modeling of Diabetes and Its Transparency- A Report on the Eighth Mount Hood Challenge

    Jun 1, 2018, 00:00
  • Agreement among the Productivity Components of Eight Presenteeism Tests in a Sample of Health Care Workers

    Jun 1, 2018, 00:00
  • A Transparent and Consistent Approach to Assess US Outpatient Drug Costs for Use in Cost-Effectiveness Analyses

    Jun 1, 2018, 00:00
  • Evaluation of Split Version and Feedback Module on the Improvement of Time Trade-Off Data

    Jun 1, 2018, 00:00
  • Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures- Summary of an FDA and Critical Path Institute Workshop

    Jun 1, 2018, 00:00
  • Table of Contents

    Jun 1, 2018, 00:00
  • Impact of Medicaid Treatment Access Policies on the Hepatitis C Epidemic

    May 1, 2018, 00:00
  • Gastrointestinal Risk Factors and Patient-Reported Outcomes in Ankylosing Spondylitis of Korea

    May 1, 2018, 00:00
  • A Systematic Literature Review of the Metholodigcal Approaches and Conclusions from Published Cost-Effectiveness Models in the Treatment of Aggressive B-Cell Lymphomas

    May 1, 2018, 00:00
  • How Values Inform the Health Policy Decision-Making Processes About Health-System Financing in Latin America? A Critical Interpretive Synthesis

    May 1, 2018, 00:00
  • The 2018 US Payor Landscape- Trends And Results from Formulary Management Surveys

    May 1, 2018, 00:00
  • Disparity in Receiving Diagnostic Workup and Treatment Among Children with Refractory Epilepsy

    May 1, 2018, 00:00
  • Cost-Utility Analysis Comparing Abobotulinumtoxina with Onabotulinumtoxina for the Treatment of Pediatric Lower Limb Spasticity

    May 1, 2018, 00:00
  • Cost-Effectiveness Analysis of Myostrain in the Early Detection of Heart Failure Patients

    May 1, 2018, 00:00
  • Economic Evaluation of the Mobile Electron Accelerator for Intraoperative Radiotherapy in Patients with Breast Cancer

    May 1, 2018, 00:00
  • Examining Costs, Utilization, and Driving Factors of Complementary and Alternative Medicine (CAM) Services

    May 1, 2018, 00:00
  • Treatment Outcome Priorities for Youth with Multi-Morbid Mental Health Conditions- A Latent Class Analysis of a Best-Worst Scaling Experiment

    May 1, 2018, 00:00
  • Long-Term Users of Benzodiazepines in Colombia- Patterns of use and Cessation of Treatment

    May 1, 2018, 00:00
  • Development of a Patient-Reported Outcome (PRO) Instrument for Patients with Acquired Thrombotic Thrombocytopenic Purpura

    May 1, 2018, 00:00
  • Treatment Strategies in Children with Severe Sickle Cell Disease after the Introduction of L-Glutamine Powder- A Decision Analysis

    May 1, 2018, 00:00
  • Understanding Economic Models in Medical Devices- An Organization’s Perspective

    May 1, 2018, 00:00
  • A Study of Peripheral Lower-Extremity Diseases-Related Hospitalization Discharge Status and its Association with Diabetes Using a US National Database

    May 1, 2018, 00:00
  • Analysis of Sociodemographic Determinants of Adverse Drug Events- Using the National Inpatient Sample Database

    May 1, 2018, 00:00
  • Comparison of Methods to Estimate Disease-Related Cost in the Truven Marketscan Adminstrative Claims Database

    May 1, 2018, 00:00
  • Cost-Effectiveness Of Sacubitril/Valsartan In The Treatment Of Heart Failure In Brazil

    May 1, 2018, 00:00
  • The Effect of Patient-Centered Oncology Care on Healthcare Utilization and Cost- A Systematic Review and Meta-Analysis

    May 1, 2018, 00:00
  • Relationship Between Health State And Patient Reported Outcome In Cutaneous T-Cell Lymphoma- An Exploratory Analysis

    May 1, 2018, 00:00
  • Economic Value of Next Generation Sequencing Panels in Oncology - A Market Development Perspective

    May 1, 2018, 00:00
  • Postoperative Complication Rate of three Different Surgeries in the Treatment of Lung Cancer in Chinese Patients- Literature Review and Single-Arm Meta-Analysis

    May 1, 2018, 00:00
  • Cost-Utility Analysis of Istent Trabecular Micro-Bypass Stent Versus Medications Only for Patients with Open-Angle Glaucoma in Colombia

    May 1, 2018, 00:00
  • Cost Effectiveness of Tobramycin Versus Azithromycin as First-Line Therapy for Acute Exacerbations Among Patients with Non-Cystic Fibrosis Bronchiectasis

    May 1, 2018, 00:00
  • National Health and Nutrition Examination Survey (NHANES) Analysis of the USA'S Obese Population and Related Comorbidities

    May 1, 2018, 00:00
  • Development of A Coordinated Registry Network for Women's Health Technologies

    May 1, 2018, 00:00
  • Comparing Rates and Reasons for Medication Non-Adherence Across Seventeen Disease Conditions, Three Modes of Administration, And two Frequencies of Administration, Using the Medication Adherence Reasons Scale (MAR-SCALE)

    May 1, 2018, 00:00
  • Challenges to Reducing Low-Value Care- Lessons Learned and Future Directions

    May 1, 2018, 00:00
  • Using Aggregate Data to Proxy Individual-Level Characteristics in Health Services Research- 9-Digit Zipcode Vs. CENSUS Block Group

    May 1, 2018, 00:00
  • Global Cost Effective Analysis Of Apixaban Versus Warfarin For The Prevention Of Stroke As A Result Of Atrial Fibrillation- A Systematic Review

    May 1, 2018, 00:00
  • Budget Impact Analyses- Inconsistency and Bias in Choice of Reporting Measures

    May 1, 2018, 00:00
  • Systematic Review and Network Meta-Analysis of Approved Medicines for the Treatment of Idiopathic Pulmonary Fibrosis

    May 1, 2018, 00:00
  • Risk of Subsequent Migraine Events after Treating Migraine with Opioids Among Mississippi Division of Medicaid Beneficiaries

    May 1, 2018, 00:00
  • Reporting of "Benefit-Risk" Studies for Medical Devices in Published Literature

    May 1, 2018, 00:00
  • The Feasibility of Utilizing Pharmacogenomics-Based Testing Techniques in the Treatment of HIV/AIDS- A Systematic Review

    May 1, 2018, 00:00
  • Older Patients’ Perception to Deprescribing In Resource Limited Settings- A Cross Sectional Study in an Ethiopia University Hospital

    May 1, 2018, 00:00
  • The Past, Present and Future of Multi-Criteria Decision Analysis (MCDA) Applied in Medical Field

    May 1, 2018, 00:00
  • Cdfs and Pdfs- Comparing Visual Methods Supporting Responder Thresholds in Clinical Trials

    May 1, 2018, 00:00
  • Differences in HPV Vaccine Uptake by Nativity Status Among American Men Aged 18-32

    May 1, 2018, 00:00
  • Natural Language Processing Methods Enhance Mace Identification from Electronic Health Records

    May 1, 2018, 00:00
  • Economic Burden of Myasthenia Gravis in the US- A Literature Review

    May 1, 2018, 00:00
  • Analytic Model to Estimate Economic Burden of Suboptimal Caloric Intake and Gastrointestinal Complications Related with Enteral Nutrition Support in Critically Ill Patients

    May 1, 2018, 00:00
  • Metformin use and the Risk of Breast, Ovarian, Endometrial, and Cervical Cancers in Elderly Females in the USA

    May 1, 2018, 00:00
  • An Observational Study of Ivacaftor in Patients with Cystic Fibrosis and Selected Non-G551D Gating Mutations in UK, Italy and Netherlands- Healthcare Resource Utilization from the First Interim Analysis of the Vocal Study

    May 1, 2018, 00:00
  • Cost-Effectiveness Analysis of Liraglutide Versus Insulin Glargine in Chinese Patients with Type 2 Diabetes Insufficiently Controlled on Metformin

    May 1, 2018, 00:00
  • Benefit Of Abiraterone Acetate Plus Prednisone (AA+P) Added To Androgen Deprivation Therapy (ADT) In Patients With High-Risk, Newly Diagnosed Metastatic Hormone-Sensitive Prostate Cancer (MHSPC)- Post Hoc Analysis Of EQ-5D-5L From The Latit ...

    May 1, 2018, 00:00
  • Difficulty of Measuring Dose Response Due to Unreliability of Days Supply in Administrative Claims Data

    May 1, 2018, 00:00
  • Healthcare Utilization of Metformin in Patients with Type 2 Diabetes and Either Congestive Heart Failure, Liver Impairment or Renal Impairment

    May 1, 2018, 00:00
  • Cost-Effectiveness Analysis of Umeclidinium Bromide/Vilanterol 62.5/25 MCG Versus Tiotropium/Olodaterol 5/5 MCG in Symptomatic Patients with Chronic Obstructive Pulmonary Disease in Spain

    May 1, 2018, 00:00
  • Real World, Prospective, Observational, Patient Reported Outcome Study of Hydroxyzine Hydrochloride in Indian Patients with Chronic Pruritis

    May 1, 2018, 00:00
  • Incidence of Hepatocellular Carcinoma and Extrahepatic Cancers Among HCV-Infected Patients in the Era of Direct-Acting Antivirals

    May 1, 2018, 00:00
  • A Large-Scale Cross-Sectional Survey on Needle-Stick Injuries Related to Injections of Antidiabetics in China- Incidence and Infection Rates

    May 1, 2018, 00:00
  • Identifying Adherence Barriers To Oral Endocrine Therapy (OET) Among Breast Cancer Patients

    May 1, 2018, 00:00
  • Economic Modelling of Chronic Kidney Disease- A Systematic Literature Review to Inform Conceptual Model Design

    May 1, 2018, 00:00
  • Factors Associated with Late Presentation for HIV Care Among Antiretroviral Therapy Clinic Registrants in Eastern Ghana- an Analytic Cross Sectional Study, 2013

    May 1, 2018, 00:00
  • Mothers’ Preferences and Willingness to Pay for Human Papillomavirus Vaccination for Their Daughters- A Discrete Choice Experiment in Hong Kong

    May 1, 2018, 00:00
  • Biosimilar Infliximab Utilization After Patent Expiry- The Case of Colitis Ulcerosa and Rheumatoid Arthritis in Hungary

    May 1, 2018, 00:00
  • Variation in Hepatitis C Drug Utilization Across State Medicaid Programs

    May 1, 2018, 00:00
  • How to Capture Authentic Patients' and Caregivers' Experience with Disease and Treatment- Establishing Trust with the "Gatekeepers" of Information

    May 1, 2018, 00:00
  • Analysis of Social Media Data Using Qualitative Methods- Understanding Preferences and Perceptions of Biologic Medications Among Patients with Severe Asthma

    May 1, 2018, 00:00
  • Cost-Effectiveness of Daclizumab Versus Interferon Beta-1A in the Treatment of Patients with Relapsing-Remitting Multiple Sclerosis in the United States

    May 1, 2018, 00:00
  • Cost-Effectiveness Of Rivaroxaban Compared With Combined Low Molecular Weight Heparin/Vitamin K Antagonist For The Treatment Of Pulmonary Embolism In China

    May 1, 2018, 00:00
  • Approaches for Estimating the Comparative Efficacy of Treatments for Patients with Recurrent Small Cell Lung Cancer (SCLC) within Connected and Disconnected Networks of Evidence

    May 1, 2018, 00:00
  • Secukinumab Prescribing Patterns in Patients with Psoriatic Arthritis in the United States- Data from Secukinumab Service Request Forms

    May 1, 2018, 00:00
  • An Economic Evaluation of a Familial Cancer Risk Management Program for Brca Mutation Carriers- An Australian Perspective

    May 1, 2018, 00:00
  • Heterogeneity in Preferences for Medical Male Circumcision Services- A Discrete Choice Experiment Among Uncircumcised Men In Fishing Communities in Uganda

    May 1, 2018, 00:00
  • Implications of Brexit on European Pharmaceutical Market Access

    May 1, 2018, 00:00
  • Emergency Room Visits and Out of Pocket Expenditure Among Individuals Enrolled in a High Deductible Health Plan

    May 1, 2018, 00:00
  • Descriptive Analysis of Commercially Insured Adult Opioid Users in The United States without Cancer or Hospi 2007-2015

    May 1, 2018, 00:00
  • Oncology Combination Pricing- Impact of Number of Competitors and Ownership Dynamics

    May 1, 2018, 00:00
  • Medication Usage, Length of Stay and Hospital Charges in Schizophrenia Patients- A Retrospective Analysis of a Large US Electronic Health Record Database

    May 1, 2018, 00:00
  • A Pilot Study on Cost Evaluation of Urgent Start Automated Peritoneal Dialysis and Hemodialysis in the Treatment of End-Stage Renal Disease in São Paulo, Brazil

    May 1, 2018, 00:00
  • The Application of Electronic Medical Records (EMRS) as a Virtual Comparator Arm in a Lung Cancer Clinical Trial

    May 1, 2018, 00:00
  • Cost/Effectiveness Analysis of Direct-Acting Antivirals for Hepatitis C Virus in Treatment-Naive Genotype 1 without Cirrhosis Patients in Spanish Population

    May 1, 2018, 00:00
  • Comparative Safety of Sleep Prescriptions and Suicide Attempts in Veterans

    May 1, 2018, 00:00
  • Impact of Depression and Anxiety on the Quality of Life at the Population Level

    May 1, 2018, 00:00
  • Budget Impact Analysis of Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in Specialties Hospital In Ecuador

    May 1, 2018, 00:00
  • Economic Impact of Calcium free Balanced Solution Versus 0.9% Saline in Sirs Patients- A Brazilian Public Hospital Perspective

    May 1, 2018, 00:00
  • Bilateral Treatment in Patients with Neovascular Age-Related Macular Degeneration- A Retrospective Cohort Study in the US

    May 1, 2018, 00:00
  • Potential Budget Impact Of High-Cost Therapies With Potential For Expanded Indications

    May 1, 2018, 00:00
  • Healthcare Cost of Potential Glucocorticoid-Associated Adverse Events in Patients with Giant Cell Arteritis

    May 1, 2018, 00:00
  • Number of Procedures for Peripheral Arterial Disease in Brazilian Private Healthcare System- A RWD Secondary Analysis

    May 1, 2018, 00:00
  • The Effect of Medication Choice After Tumor Necrosis Factor Inhibitor (TNFI) use on the Healthcare Costs for Patients with Rheumatoid Arthritis- An Instrumental Variables Approach

    May 1, 2018, 00:00
  • Cost-Effectiveness of Ceftolozane/Tazobactam Plus Metronidazole as Empiric Therapy for the Treatment of Complicated Intra-Abdominal Infections in Colombia

    May 1, 2018, 00:00
  • Assessing the Burden of Disease-Associated Malnutrition Among Hospitalized Malnourished Colombian Patients with Heart and Lung Disease

    May 1, 2018, 00:00
  • How are we Measuring Access to Healthcare in the US? — an Environmental Scan of Quality Measures

    May 1, 2018, 00:00
  • Costs of Hodgkin and Non-Hodgkin Lymphoma in Fran Results on the Basis of the French National Health Insurance Database

    May 1, 2018, 00:00
  • Incorporating Homomorphically Encrypted Data in Studies of Real-World Evidence to Support Expanded Approvals of Cancer Treatments

    May 1, 2018, 00:00
  • Economic Consequences of Clinically Important Deterioration in Patients with Chronic Obstructive Pulmonary Disease- Analysis of the Torch Study

    May 1, 2018, 00:00
  • Cost-Effectiveness Of Rivaroxaban Compared With Real-World Treatment For Stroke Prevention In Non-Valvular Atrial Fibrillation In China

    May 1, 2018, 00:00
  • Cost-Effectiveness Analysis of Palbociclib for the Treatment of Patients with HR+/HER2− Advanced/Metastatic Breast Cancer in Bulgaria

    May 1, 2018, 00:00
  • Economic Evaluation of Ramucirumab as Second-Line Chemotherapy for Previously Treated Advanced Gastric or Gastro-Oesophageal Junction Adenocarcinoma in China

    May 1, 2018, 00:00
  • Day-To-Day Fluctuations in Older Adults' Cognitive Functioning- Moving Beyond Single Time Point Assessments

    May 1, 2018, 00:00
  • Assessing Sleep Impact in Patients with Nocturia Disorder

    May 1, 2018, 00:00
  • Economic Burden of Non–Communicable Diseases (NCDS) In Poland

    May 1, 2018, 00:00
  • Benchmarking HIV Quality Measures Across US Payer Types

    May 1, 2018, 00:00
  • Selective Serotonin Reuptake Inhibitors and Bone Mass Density

    May 1, 2018, 00:00
  • Patient Performance Indicators- Decomposition of Patient Medication Adherence

    May 1, 2018, 00:00
  • Adaption and Validation of the Adherence Barriers Questionnaire for HIV Patients with Antiretroviral Therapy

    May 1, 2018, 00:00
  • Apixaban Compared With Low Molecular Weight Heparins For Prophylaxis In The Patients At Risk Of Venous Thromboembolism- A Systematic Review And Meta-Analysis

    May 1, 2018, 00:00
  • Assessing the Cost-Effectiveness of Three-Monthly Paliperidone Palmitate Versus its Prior Monthly Formulation for the Management of Schizophrenia in the UK Setting

    May 1, 2018, 00:00
  • Assessing Chronic Disease Medication Adherence

    May 1, 2018, 00:00
  • Trends in Hospitalization Lenght of Stay and Costs in Patients with Primary Immunodeficiency- Analysis of US National In-Patient Data for 2015

    May 1, 2018, 00:00
  • Assessement of the Challenges Associated with Drug Innovation in Post-Traumatic Stress Disorder

    May 1, 2018, 00:00
  • Role of Patient-Reported Outcome Evaluation in the Approval of Orphan Drugs- A Review of 15 Year Approvals by the FDA and the EMA

    May 1, 2018, 00:00
  • The Costs of Intensification from Basal Insulin to Basal-Bolus in Type 2 Diabetes- A Survey of Physicians

    May 1, 2018, 00:00
  • A Critical Assessment Of The Role Of Health Outcomes Liaisons- Today And The Future

    May 1, 2018, 00:00
  • Estimating the Lifetime Costs in Adult Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma in the United States

    May 1, 2018, 00:00
  • Development of a Conceptual Model and Review of Patient-And Observer-Reported Outcome Measures in Atopic Dermatitis

    May 1, 2018, 00:00
  • The Promising Role of Pembrolizumab in the Management of Patients with Pd-L1-Positive Non-Small Cell Lung Cancer- A Systematic Review

    May 1, 2018, 00:00
  • Budgetary Impact and Cost Drivers of Drugs for Rare and Ultrarare Diseases

    May 1, 2018, 00:00
  • Cognitive Debriefing Interviews to Explore the Content Validity of the Chronic Liver Disease Questionnaire (CLDQ) and Eq-5D-5L in Patients with Chronic Hepatitis B

    May 1, 2018, 00:00
  • Cancer Mortality Trends In Brazil And Mexico

    May 1, 2018, 00:00
  • A Systematic Literature Review to Assess the Current Evidence Landscape for Digital Behaviour Interventions in Multiple Sclerosis (MS)

    May 1, 2018, 00:00
  • A Work-Sampling Study of an Innovative Pediatric Care-Coordination Program for Asthma, Diabetes, and Sickle Cell Patients

    May 1, 2018, 00:00
  • What are the Real Indirect Costs Associated with Multiple Myeloma- Model Patient Analysis From Slovak Republic

    May 1, 2018, 00:00
  • Emergency Care in Marfan Syndrome- A Retrospective Hospital Analysis

    May 1, 2018, 00:00
  • Psychotherapy and Mental Health Counseling for Children with Attention-Deficit Hyperactivity Disorder (ADHD)

    May 1, 2018, 00:00
  • Self-Reported Insomnia Symptoms and Health Related Quality of Life in the US Adult Population

    May 1, 2018, 00:00
  • The Cost-Effectiveness of Treatments in Non-Cirrhotic Saudi Arabian Patients with Genotype 1 and Genotype 4 Chronic Hepatitis C

    May 1, 2018, 00:00
  • Economic Burden of Diagnosed Chronic Migraine and Diagnosed Episodic Migraine Patients in a Large US Health Insurer’s Population

    May 1, 2018, 00:00
  • Impact Of New Guidelines For High Blood Pressure- Findings From The Om1 Data Cloud

    May 1, 2018, 00:00
  • Dengue Vaccine Efficacy- A Systematic Review

    May 1, 2018, 00:00
  • Development and Application of a Novel Patient-Reported Outcomes Instrument, The Psoriasis Symptoms and Signs Diary, Measuring Psoriasis Severity in Clinical Trials

    May 1, 2018, 00:00
  • Challenges in Comparing Remission Outcomes in Network Meta-Analyses in Ulcerative Colitis

    May 1, 2018, 00:00
  • The Cost Effectiveness Analysis of PD-1 And PD-L1 Agents Compared with Docetaxel for Second-Line Treatment of Advanced Non-Small Cell Lung Cancer

    May 1, 2018, 00:00
  • College Students' Beliefs About Prescription Drug Misuse Among Peers

    May 1, 2018, 00:00
  • The Zero Dollar Copay Disease Management Program- Lowering Healthcare Utilization in Patients with Diabetes

    May 1, 2018, 00:00
  • Assessing Cellulite Severity- Method for Assessing Reliability of a New Clinician-Reported and a New Patient-Reported Photonumeric Scale

    May 1, 2018, 00:00
  • Association Between Biochemical Control and Comorbidities and Symptoms Among Patients with Acromegaly in Italy- Stratified Analyses by Age and Gender

    May 1, 2018, 00:00
  • Evaluation of Opioid use Among Patients with Back Disorders and Arthritis

    May 1, 2018, 00:00
  • Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada

    May 1, 2018, 00:00
  • Calculating Rasch-Based Person Parameters for Individual Items

    May 1, 2018, 00:00
  • Inverse Correlation of Decreased Opioid Utilization and Increased Medical Assisted Therapy in U.S. Medicaid Managed Care

    May 1, 2018, 00:00
  • Influence Factors and Economic Burden of Antidiabetics-Injection-Related Needle-Stick Injuries in China

    May 1, 2018, 00:00
  • Combatting Rising Obesity in AMCP Dossiers? The New AMCP Dossier Format – Version 4.0

    May 1, 2018, 00:00
  • The Clinical Value of Early Diagnosis Tests for the Long-Term Management of Dementia

    May 1, 2018, 00:00
  • The Increasing Global Incidence of Ulcerative Colitis; Implications for the Economic Burden of Ulcerative Colitis

    May 1, 2018, 00:00
  • The Economic Burden of Mechanically Ventilated Patients with Pneumonia in the US

    May 1, 2018, 00:00
  • Opioid Analgesic Prescribing Related to Dental Visits in the Mississippi Medicaid Population

    May 1, 2018, 00:00
  • Comparing Short Form – 6 Dimension (SF-6D) Derived Utilities and Euroqol Questionnaire – 5 Dimensions (EQ-5D) Mapped Utilities Among Patients with Iron Deficiency in Inflammatory Bowel Disease (ID-IBD) Treated with Ferric Maltol (FM) Vs Pla ...

    May 1, 2018, 00:00
  • Trends in Utilization of Endovascular Arterial Revascularization Modalities Below the Knee in Germany 2009-16

    May 1, 2018, 00:00
  • Therapy For Glioma- Indian Market Overview

    May 1, 2018, 00:00
  • Findings from the 2018 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Student Interest Survey

    May 1, 2018, 00:00
  • Cognitive and Mind-Body Therapies for the Treatment of Chronic Low Back Pain – A Cost-Effectiveness Analysis

    May 1, 2018, 00:00
  • GLP-1 Non-Persisten A Survey of Adults with Type 2 Diabetes in the UK and USA

    May 1, 2018, 00:00
  • Biopsy Procedures in Patients with Primary Lung Cancer

    May 1, 2018, 00:00
  • Estimating the Impact of Affordable Care Act (ACA) on Likelihood of Receiving Mammography and PAP Smear Screenings

    May 1, 2018, 00:00
  • Web-Based Computerized Adaptive Testing Via An Open-Source Platform

    May 1, 2018, 00:00
  • Real World Evidence for Effectiveness of Biologics for Rheumatoid Arthritis- Systematic Literature Review of Population Based Registry Studies

    May 1, 2018, 00:00
  • Patient Reported Outcomes In Metastatic Renal Cell Carcinoma Patients Receiving Pazopanib In A Community Oncology Setting

    May 1, 2018, 00:00
  • Cost Per Responder Analysis of Guselkumab Versus Etanercept Using Efficacy Results from Pivotal Clinical Trials in Patients with Moderate to Severe Plaque Psoriasis

    May 1, 2018, 00:00
  • Impact of Psychosocial Factors on Health Services Utilization and Cost of Care in Blood and Marrow Transplant Patients

    May 1, 2018, 00:00
  • Cost-Effectiveness Analysis of Cladribine Tablets for Treatment of Patients with Relapsing-Remitting Multiple Sclerosis in Bulgaria

    May 1, 2018, 00:00
  • Systematic Literature Review (SLR) Of Sequencing Of Anaplastic Lymphoma Kinase (ALK) Inhibitors In ALK-Positive Non-Small Cell Lung Cancer (NSCLC)

    May 1, 2018, 00:00
  • Taking The Burden Out Of Symptom Reporting In Patients With Melanoma Using A Digital Real-World Evidence Platform

    May 1, 2018, 00:00
  • Budget Impact for Olaparib Maintenance Therapy for Brca-Mutated Platinum Sensitive Recurrent Ovarian Cancer in Panama

    May 1, 2018, 00:00
  • Use of PD-L1 Biomarker in Second Line Therapy for Non-Small Cell Lung Cancer- Budget Impact Analysis from a Private Payer Perspective In Brazil

    May 1, 2018, 00:00
  • Patient Goup Experiences of Engagement in Health Technology Appraisals for Rare Disease Treatments - A Pilot Study in the UK

    May 1, 2018, 00:00
  • Setting the Boundaries for Economic Evaluation- Investigating Time Horizon and Family Effects in the Case of Postnatal Depression

    May 1, 2018, 00:00
  • Calculating Appropriate ICERS in Diabetes Prevention Program (DPP) Cost-Effectiveness and Overturning Misleading Conclusions Regarding Optimal Treatment

    May 1, 2018, 00:00
  • Changes in the Quality of Life(QOL) Of Patients with Type 2 Diabetes Mellitus According to the Change Of Physicians and Patients Behaviors for CV Risk Managements after Awareness of CVD Risks

    May 1, 2018, 00:00
  • Trends in Hospitalization Lenght of Stay and Costs in Endometriosis- Analysis of US National In-Patient Data for 2015

    May 1, 2018, 00:00
  • Cost-Effectiveness of Edoxaban Compared with Dalteparin for the Treatment of Cancer-Associated Venous Thromboembolism

    May 1, 2018, 00:00
  • Differences in Antidepressant Medication Management Between Commercially Insured and Traditional Medicaid for Low Income Adults in Arkansas

    May 1, 2018, 00:00
  • Impacts Of Time Spent On Rituximab Infusion On Patient Satisfaction, Stress, Employment, And Caregiver Burden

    May 1, 2018, 00:00
  • A Measure of Health-Related Quality of Life (HRQOL) Associated with Chronic Conditions Using EQ-5D-5L in Hong Kong Sar,China

    May 1, 2018, 00:00
  • Examining the Effect of Missing Data on the Acmg Newborn Screening Criteria of Least Consensus for Carnitine Palmitoyltransferase II Deficiency (CPTII)

    May 1, 2018, 00:00
  • Cost-Effectiveness Of Edoxaban Compared With Low Molecular Weight Heparin/Vitamin K Antagonist For The Treatment Of Venous Thromboembolism

    May 1, 2018, 00:00
  • Missing Value Imputation In Pragmatic Clinical Trials (PCT)- An Accuracy Analysis

    May 1, 2018, 00:00
  • Long-Term Cost-Effectiveness of Valbenazine and Deutetrabenazine For Tardive Dyskinesia

    May 1, 2018, 00:00
  • Comparative Analysis of Total Medical Expenditure of Therapy with Nebulized Budesonide and Systemic Corticosteroids for Patients with COPD Exacerbation

    May 1, 2018, 00:00
  • Healthcare Resource Utilization and Costs in Patients with Persistent Asthma by Attainment of Healthcare Effectiveness and Data Information Set (HEDIS) Measures

    May 1, 2018, 00:00
  • Free-Flap Mandibular Reconstructions- Patient Demographics And Resource Utilization in the United States

    May 1, 2018, 00:00
  • A Review of the Costs of Lower Limb Amputations in Patients With Diabetes in the US

    May 1, 2018, 00:00
  • Incidence of Depression Following Traumatic Brain Injury

    May 1, 2018, 00:00
  • Shared Decision Making and Satisfaction with Care Among Patients with Diabetes Mellitus

    May 1, 2018, 00:00
  • Barbec(EU)D Oncology Market Access – Part D(EU)X

    May 1, 2018, 00:00
  • A Mapping And Analysis Of National Accelerated Access Pathways For Cancer Drugs

    May 1, 2018, 00:00
  • Cost-Effectiveness Analysis of Midostaurin (MIDO) With Standard of Care (SOC) for Acute Myeloid Leukemia (AML) in Canada

    May 1, 2018, 00:00
  • Septic Revision of All Knee Components Following Total Knee Arthroplasty- Type and Payments for Care, and Incidence of 1-Year Re-Infection and Amputation

    May 1, 2018, 00:00
  • Systematic Review of Poly (ADP-RIBOSE) Polymerase Inhibitors for Treatment of Ovarian Cancer

    May 1, 2018, 00:00
  • Benefits of Adenotonsillectomy in Children with Mild Obstructive Sleep Apnea Syndrome

    May 1, 2018, 00:00
  • Replicating and Extending the Four-Factor Structure of the Medication Adherence Reasons Scale (MAR-SCALE) in Pain, Migraine, And Sleep Conditions Among People Using Daily and Weekly Administered Oral Medications

    May 1, 2018, 00:00
  • Utilizing Natural Language Processing and Machine Learning to Create a Better Member Experien Blue Cross Blue Shield of Louisiana (BCBSLA) Innovation in Action

    May 1, 2018, 00:00
  • Accounting for Known Unknowns in the American College Of Medical Genetics (ACMG) Recommendations for NBS- Policy Implications of Accounting for Uncertainty in Assessment in the Case of Medium Chain Ketoacyl-COA Thiolase Deficiency (MCKAT) N ...

    May 1, 2018, 00:00
  • PRO2 Based Remote Monitoring in Ulcerative Colitis- A Prospective Real World Study

    May 1, 2018, 00:00
  • The Cost of Comorbid Depression Among Patients with Rheumatoid Arthritis

    May 1, 2018, 00:00
  • Accountable and Reasonable Processes for Coverage Decision-Making for Rare Disease and Regenerative Therapies – Which Criteria Should be Considered and Why?

    May 1, 2018, 00:00
  • An Economic Evaluation of Market Forces on Orphan Drug Research Following Changes in American Tax Law

    May 1, 2018, 00:00
  • An Algorithmic Approach To Optimal Study Design for Outcomes Research

    May 1, 2018, 00:00
  • The Association Between Anti-Epileptic Drug Adherence to Sodium Channel Blockers and Health-Related Quality of Life- Analysis of US Survey Data from Patients with Epilepsy

    May 1, 2018, 00:00
  • Racial Trends in Non-Vitamin/Non-Mineral Medication Use During Pregnancy or Puerperium in the Ambulatory Care Setting

    May 1, 2018, 00:00
  • Adherence Issues in Fibromyalgia- How Can Acceptance Measurement Help Understanding Patients' Concerns and Working on Solutions?

    May 1, 2018, 00:00
  • Utilization, Reimbursement, and Price of Incretin-Based and Peptides Therapies for Type 2 Diabetes in US Medicaid Program from 2005 to 2016

    May 1, 2018, 00:00
  • The Association Between Prescription Stimulant Use and Prescription Drug Misuse

    May 1, 2018, 00:00
  • Psychometric Evaluation of the Psoriasis Symptoms Scale in Patients with Moderate to Severe Plaque Psoriasis

    May 1, 2018, 00:00
  • An International Comparison of Antineoplastic and Imunomodulating Agent Price in Thirteen Countries - Patented Medicines, Chemical Entities, and Biologics

    May 1, 2018, 00:00
  • Treatment Patterns and Economic Burden of Chinese Metastatic Colorectal Cancer Patients- a Retrospective Study of Electronic Medical Records from Urban China

    May 1, 2018, 00:00
  • Determinants of Asthma in Children- Evidence from National Survey of Children’s Health in USA

    May 1, 2018, 00:00
  • A Case Management Approach to Reducing ER Visits- A Blue Cross Blue Shield of Louisiana (BCBLSA) Case Study

    May 1, 2018, 00:00
  • A Hospital Budget Impact Model to Estimate the Impact Associated with Phasix™ and Phasix™ St Mesh Versus Stratticetm Matrix in Complex Ventral Hernia Repair Procedures

    May 1, 2018, 00:00
  • Graphical Probabilistic Models for Risk Prediction and Decision Making Using Real-World Data- A Developing Tool for the Era of Precision Medicine

    May 1, 2018, 00:00
  • Prostate Cancer Costs In Colombia- A Top-Down Approach

    May 1, 2018, 00:00
  • Reimbursement of Vedolizumab According to the Indications- what are the Impacts in the 37 Public Hospitals of Paris?

    May 1, 2018, 00:00
  • Attitudes and Beliefs Towards Psychotropic Medication in Patients with Dual Diagnosis

    May 1, 2018, 00:00
  • Economic Analysis of Abaloparatide in High-Risk Postmenopausal Women with Osteoporosis in the United States - A Discrete-Event Simulation Model

    May 1, 2018, 00:00
  • Optifast® Meal Replacement Program for the Treatment of Obesity- A Cost-Effectiveness Assessment from the Employer Perspective in the USA

    May 1, 2018, 00:00
  • Recursively Imputed Survival Trees for Extrapolating Survival Beyond Clinical Trial Follow UP- A Simulation Study

    May 1, 2018, 00:00
  • Accepting Biosimilars - what are the Doctors Looking for? - A Systematic Review

    May 1, 2018, 00:00
  • A Systematic Review of Cost-Effectiveness Analysis Studies in Newborn Screening (NBS)

    May 1, 2018, 00:00
  • The Impact of Legislative Changes and Regulatory Guidance on Proactive Dissemination of Healthcare Economic Information- Payers’ Experiences Pre and Post Product Approval

    May 1, 2018, 00:00
  • Effectiveness of Guideline-Recommended Care Bundles- A Systematic Review

    May 1, 2018, 00:00
  • Cost-Effectiveness of Short-Course Radiotherapy Compared to Long-Course Chemoradiotherapy in the Treatment of Stage Iii Rectal Cancer Patients from the US Societal Perspective

    May 1, 2018, 00:00
  • Cost Effectiveness of Anti-PD-1/PD-L1 Treatments- Systematic Review of Published Studies

    May 1, 2018, 00:00
  • Analysis the Number of Cases of One-Day Surgical Patient Care in Hungarian University Clinical Centre’s Between 2010-2015

    May 1, 2018, 00:00
  • Budget Impact Analysis of Palbociclib for the Treatment of Patients With HR+/HER2− Advanced/Metastatic Breast Cancer In Bulgaria

    May 1, 2018, 00:00
  • Machine Learning to Detect and Diagnose Atrial Fibrillation and Atrial Flutter (AF/F) Using Routine Clinical Data

    May 1, 2018, 00:00
  • Health Insurance Status and Outcomes Among Adults with Mycosis Fungoides in the United States

    May 1, 2018, 00:00
  • Cost-Effectiveness Analysis of Hepatitis C Treatments in Mexico- Genotype 2 and 3

    May 1, 2018, 00:00
  • Perceptions of Biosimilars Across Physician Specialities in Europe

    May 1, 2018, 00:00
  • Health Economic Model for Estimating the Direct Cost Impact of Adopting a Vascular Access Antimicrobial Bundle of Solutions in ICU Settings in Germany

    May 1, 2018, 00:00
  • The Impact of Ophthalmology in the Hungarian One-Day Surgery

    May 1, 2018, 00:00
  • Impact of Initiating Long-Acting Injectables on All-Cause and Psychiatric Hospitalization in Patients With Bipolar I Disorder

    May 1, 2018, 00:00
  • The Growing Number Of High-Cost Advanced Therapy Medicinal Products (ATMPS) Pose Unprecedented Pricing And Funding Challenges To Current Models Of Healthcare

    May 1, 2018, 00:00
  • Use of Disease Modifying Agents in Patients With Multiple Sclerosis- Analysis of Ten Years of National Data

    May 1, 2018, 00:00
  • Association Between Age at Initiation of Regular Cigarette Smoking and Age at Initiation Of Substance Use- A Cohort Study

    May 1, 2018, 00:00
  • Current Management of Specialty Drugs, Specialty Pharmacies and Biosimilar Drugs

    May 1, 2018, 00:00
  • Systematic Literature Review (SLR) Of Health State Utility Values (HSUV) In Epidermal Growth Factor Receptor Mutant (Egfr-Mutant) Non-Small Cell Lung Cancer (NSCLC) Patients Previously Treated With Targeted Therapies

    May 1, 2018, 00:00
  • Effect of Chronic Condition Special Needs Plan Enrollment on Outcomes for Medicare Beneficiaries

    May 1, 2018, 00:00
  • Can Severity Outweigh Smaller Numbers? A Deliberative Perspective from Canada

    May 1, 2018, 00:00
  • The Long-Term Benefits of Ensuring Timely Treatment and Improved Medication Adherence in Early Schizophrenia- A Microsimulation Study

    May 1, 2018, 00:00
  • Cost-Effectiveness of Paliperidone Palmitate Long-Acting Injectable Versus Oral Antipsychotics For The Treatment Of Patients With Schizophrenia In Peru

    May 1, 2018, 00:00
  • The Impact of Long Acting Injectable Medications on Patient Outcomes

    May 1, 2018, 00:00
  • Online Methods for the Electronic Validation of the Treatment Satisfaction for Medication Questionnaire

    May 1, 2018, 00:00
  • Prevalence of Latent Tuberculosis Infection in Patients with Rheumatoid Arthritis in Colombia- A Single Setting Study

    May 1, 2018, 00:00
  • Pharmacy Closures and Adherence to Cardiovascular Medications Among Older Adults in the U.S

    May 1, 2018, 00:00
  • Discontinuation, Switching and Restarting Among Migraine Patients Initiating Prophylaxis

    May 1, 2018, 00:00
  • Heart Rate Variability Testing- Could it Change Spending for Rheumatoid Arthritis Patients in the United States? An Exploratory Economic Analysis

    May 1, 2018, 00:00
  • A Retrospective Analysis of Tack Use With Progrip™ Laparoscopic Self-Fixating Mesh and 3dmax™ Mesh in Outpatient Hospital Inguinal Hernia Repair Procedures

    May 1, 2018, 00:00
  • Incorporating Reimbursement and Health Economics (RHE) into the New Product Development Process

    May 1, 2018, 00:00
  • Burden Of Disease Of Acute Myocardial Infarction In Hungary

    May 1, 2018, 00:00
  • Personal Income Before and After Diagnosis of Multiple Sclerosis

    May 1, 2018, 00:00
  • A Retrospective Observational Study on Characteristics and Medical Resource Utilization of Long-Term Hospitalization Patients in China

    May 1, 2018, 00:00
  • Approvals and Pricing of Factor VIII and Factor IX Concentrates for Hemophilia A and B in the United States

    May 1, 2018, 00:00
  • 2018 Update Of Health Technology Assessment Decisions Across The Globe- A Focus On Oncology

    May 1, 2018, 00:00
  • Cost-Effectiveness Analysis of Rucaparib Maintenance Treatment for Recurrent Ovarian Carcinoma after Response to Platinum Therapy

    May 1, 2018, 00:00
  • Real World, Non-Interventional, Observational Study to Evaluate Effectiveness and Tolerability of Acotiamide Hydrochloride Hydrate in Indian Patients with Functional Dyspepsia

    May 1, 2018, 00:00
  • Using Real-World Evidence for Health Technology Assessment Submissions- Lessons and Insights from Review Of Nice’s Technology Assessment Reports (2016-2017)

    May 1, 2018, 00:00
  • Treatment Patterns, Healthcare Resource Utilization And Associated Costs By Line Of Therapy In Newly Diagnosed Merkel Cell Cancer Patients In The United States

    May 1, 2018, 00:00
  • Role of Patient Assistance Program (PAP) in Market Access and Outcomes- Insights from Systematic Literature Review (2013-2017)

    May 1, 2018, 00:00
  • Review of Operative Outcomes of Robotic Surgical Procedures Performed with Robotic vs. Endoscopic Linear Staplers

    May 1, 2018, 00:00
  • Cost-Effectiveness of Donepezil in the Treatment of Patients With Alzheimer's Disease- An Update

    May 1, 2018, 00:00
  • Bridging the Consumerization of Healthcare into the Laboratory Test Setting

    May 1, 2018, 00:00
  • Prescription Opioid Use Before and after An Overdose Event in Mississippi Medicaid

    May 1, 2018, 00:00
  • Cost-Effectiveness of Regular Utilization of Zoledronic Acid for Developed Bone Metastases from Advanced Breast Cancer in Chinese Patients

    May 1, 2018, 00:00
  • Psychosocial and Other Non-Drug Treatments for Bipolar Disorder in Adults- A Systematic Review

    May 1, 2018, 00:00
  • Assessing Quality in Qualitative Research to Understand Disease Burden; What Tools are Available?

    May 1, 2018, 00:00
  • Modifiable Risk Factors and Population Attributable Risk of Obesity Among High School Students in the U.S

    May 1, 2018, 00:00
  • How Will Payers Manage The High Cost Of Combinations Of New Oncology Agents, As Many Of These Therapies Become The Preferred Treatment Options To Optimize Patient Outcomes?

    May 1, 2018, 00:00
  • Medication Synchronization Improves Medication Adherence

    May 1, 2018, 00:00
  • Cost-Effectiveness of Crizotinib, Ceritinib, and Alectinib as First-Line Treatments for Anaplastic Lymphoma Kinase-Positive (ALK+) Metastatic Non-Small Cell Lung Cancer

    May 1, 2018, 00:00
  • Analysis of Success Rates for the Center for Medicare and Medicaid’s New Technology Add-On Payment Program

    May 1, 2018, 00:00
  • Economic Impact of Absenteeism and Deaths Due to Pneumonia in Brazilian Economy

    May 1, 2018, 00:00
  • Applying Population Health Management Techniques to Lower Healthcare Utilization in Patients with Non-Chronic Complex Diseases

    May 1, 2018, 00:00
  • Cost and Utility in Recipients of Autologous Hematopoietic Stem Cell Transplant (Auto-HSCT) Who Developed Herpes Zoster (HZ) During the Phase 3 Trial of Inactivated Varicella-Zoster Vaccine (ZVIN)

    May 1, 2018, 00:00
  • Missing Data in Patient-Reported Outcomes- Regulatory, Statistical, and Operational Perspectives

    May 1, 2018, 00:00
  • Cost-Effectiveness of Mepolizumab Versus Omalizumab as an Adjunct Therapy in Patients with Uncontrolled Allergic Asthma

    May 1, 2018, 00:00
  • Cost-Effectiveness of Therapeutic Drug Monitoring for Imatinib Administration in Patients with Chronic Myeloid Leukemia

    May 1, 2018, 00:00
  • Sociodemographic Population and Health Profiles of Self-Identified Middle Eastern/North African Medicaid Beneficiaries in Managed Care

    May 1, 2018, 00:00
  • The Zero Dollar Copay Disease Management Program- Lowering Healthcare Utilization In Patients With Chronic Diseases

    May 1, 2018, 00:00
  • Assessing Hospital Utilization of Patients Diagnosed with Marfan Syndrome

    May 1, 2018, 00:00
  • Outcomes Among Medicaid Recipients with Schizophrenia Treated with Once-Every-Three Month Paliperidone Palmitate

    May 1, 2018, 00:00
  • Identification of Surgical Bleeding Complications in the Linked U.K. Clinical Practice Research Datalink Hospital Episode Statistics Databases- Impact of Varying Definitions on Incidence and Association with Hospital Length of Stay

    May 1, 2018, 00:00
  • The Professionals’ Perspective of Patient Involvement in Market Access- A Descriptive Analysis

    May 1, 2018, 00:00
  • Survey Results of Contemporary Us Health Plan Policies – Affordable Care Act (ACA), Digital Technologies, Value Based Contracting (VBC) And Comparative Effectiveness Research (CER)

    May 1, 2018, 00:00
  • Health Care Costs Associated with Different Biologic Treatment Patterns Among U.S. Medicare Patients with Psoriasis

    May 1, 2018, 00:00
  • Barriers Impeding the Availability and Uptake of Biosimilars in The US

    May 1, 2018, 00:00
  • Estimating the Health State Utility of Patients with HER2– gBRCA+ Metastatic Breast Cancer Treated with Olaparib or Chemotherapy Via A Mapping Analysis of Eortc QLQ-C30 Data Collected in the Olympiad Clinical Trial

    May 1, 2018, 00:00
  • Symptoms And Impacts In Advanced/Metastatic Gastric Or Gastroesophageal Junction Cancer- Findings From Qualitative Patient Interviews

    May 1, 2018, 00:00
  • Cost-Effectiveness Of Rivaroxaban Compared With Enoxaparin Plus Warfarin For The Treatment Of Acute Deep Vein Thrombosis In China

    May 1, 2018, 00:00
  • An Analysis of Healthcare Utilization and Costs Associated with Patients with Acute Hepatic Porphyrias (AHPS) with Recurrent Attacks in Explore- A Prospective, Multinational Natural History Study of Patients with AHP

    May 1, 2018, 00:00
  • Efficacy and Inhibitor Development of Prophylactic vs On-Demand Factor VIII and IX in the Management of Haemophilia Patients from Southeast Asia- A Systematic Review

    May 1, 2018, 00:00
  • Shared Decision-Making in Children and Adolescents with Mental Health Conditions

    May 1, 2018, 00:00
  • Orphan legislation - Leave No One Behind?

    May 1, 2018, 00:00
  • Icer Reports – 4 Years of Cost/Qaly Drug Evaluations in the USA… what Does the Future Hold?

    May 1, 2018, 00:00
  • Clinical Characteristics, Treatment Patterns, And Health Care Resource Utilization In Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer- A Medical Record Review Study In The United States And Canada

    May 1, 2018, 00:00
  • Cost-Effectiveness of Niraparib Versus Routine Surveillance and Olaparib for the Maintenance Treatment of Adult Patients with Ovarian Cancer in the United States

    May 1, 2018, 00:00
  • Projected Medicare Savings Associated with Lowering the Risk of Total HIP Arthroplasty Revision- An Administrative Claims Database Analysis

    May 1, 2018, 00:00
  • Changes of Health Insurance Sick-Pay Expenditures in Hungary Between 2008-2016

    May 1, 2018, 00:00
  • Assessing the Economic Burden and 30-Day Readmission Rates Among Patients with Chronic Obstructive Pulmonary Disease in the US Veterans Health Administration Population

    May 1, 2018, 00:00
  • Impact of the Hitech Act’s Incentive Program on the Adoption of Drug-Drug Interaction Alerts and Electronic Prescribing in the Ambulatory Care Setting

    May 1, 2018, 00:00
  • Prevalence and Correlates of Pharmacy Closure in the United States, 2009-2015

    May 1, 2018, 00:00
  • Comparing the Epidemiology of ADPKD in the US from 2010-2015 Using one Versus two Diagnosis Codes in Claims Data

    May 1, 2018, 00:00
  • Antecedents of Patient Participation in Prescription Medication Decision

    May 1, 2018, 00:00
  • Economic Impact of French Public Regulations on Ferric Carboxymaltose in 39 Paris Public Hospitals Over the 2013-2016 Period

    May 1, 2018, 00:00
  • Cost Analysis Model for the Treatment of Acute Agitation Among Patients with Schizophrenia in China

    May 1, 2018, 00:00
  • Evaluating the Relationship Between In-Utero Methylprednisolone Exposure and Birth Defects

    May 1, 2018, 00:00
  • The Cost of Drugs for Age-Related Macular Degeneration in Canada and Internationally

    May 1, 2018, 00:00
  • Evaluation of Potentially Inappropriate Medications and Clinical Outcomes in Older Adults Admitted to the Medical Intensive Care Unit

    May 1, 2018, 00:00
  • Understanding Sepsis Recognition and Management in Emergency Room Settings to Improve Patient Outcomes

    May 1, 2018, 00:00
  • Epidemiology of Meningococcal Disease Among Individuals in a Managed Care Population Over A 17-Year Period (1999-2016)

    May 1, 2018, 00:00
  • Comparing Literature Review Requirements for Reimbursement Submissions Across the Globe

    May 1, 2018, 00:00
  • Geographic Variation in Utilization of Physician Services Among Older Adults Diagnosed with Non-Hodgkin Lymphoma

    May 1, 2018, 00:00
  • Cost-Minimization Analysis of Biological Drugs in the Treatment of Psoriatic Arthritis from a Brazilian Perspective

    May 1, 2018, 00:00
  • Patterns of Post-Diagnosis Depression Among Late-Stage Cancer Patients- Do Racial/Ethnic and Gender Disparities Exist?

    May 1, 2018, 00:00
  • Comparative Effectiveness Of Apixaban Versus Warfarin For The Prevention Of Recurrent Venous Thromboembolism And Cardiovascular Diseases In Patients With Venous Thromboembolism

    May 1, 2018, 00:00
  • A Prospective Clinical Observational Study on Assessment of Risk Factors, Diagnosis and Prescribing Patterns of Medications for Migraine

    May 1, 2018, 00:00
  • Costs of Complications in Laparoscopic Bariatric Surgery

    May 1, 2018, 00:00
  • Effectiveness and Costs of Conventional Dmard Therapy in Patients with Rheumatoid Arthritis

    May 1, 2018, 00:00
  • Effect of Depression on Adherence to Controller Medications and Healthcare Resource Utilization in Asthma Patients

    May 1, 2018, 00:00
  • Analytic Model to Estimate Costs of two Dialysis Modalities in Paraguay

    May 1, 2018, 00:00
  • The Budget Impact of Deflazacort for the Treatment of Duchenne Muscular Dystrophy (DMD)

    May 1, 2018, 00:00
  • Comparative Effectiveness of Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation

    May 1, 2018, 00:00
  • Cost Analysis of Medication Therapy Management - Using Propensity Score Matching Method

    May 1, 2018, 00:00
  • Factors Related to Non-Integrated or Fragmentation Polypharmacy in A Colombian Population

    May 1, 2018, 00:00
  • Does The Traditional Hta Process Appropriately Evaluate Brand+Brand Oncology Combination Drugs?

    May 1, 2018, 00:00
  • Healthcare Utilization and Cost Among Patients with Hereditary Transthyretin (HATTR) Amyloidosis

    May 1, 2018, 00:00
  • Medical Resource Utilization and Expenditures in Texas Medicaid Patients Taking Deferasirox Dispersible Tablets and Those Taking Deferasirox Film-Coated Tablets

    May 1, 2018, 00:00
  • Belimumab for the Treatment of Adults Living with Active Systemic Lupus Erythematosus- A Cost-Effectiveness Analysis in Canada

    May 1, 2018, 00:00
  • Hospitalisation Rate as a Proxy Outcome for Clinical Value in a Protocolised Cancer Treatment Environment

    May 1, 2018, 00:00
  • Cancer Drug Recommendations Without Statistically Significant Overall Survival By The Pan-Canadian Oncology Drug Review

    May 1, 2018, 00:00
  • Reasons for Non-Adherence with Statins Among Patients Who Had a Primary Cardiovascular Disease Event

    May 1, 2018, 00:00
  • Trends in Regional Variation Among Inpatients with Breast Cancer in the United States- Analysis of 2010-2014 Healthcare Cost and Utilization Project Data

    May 1, 2018, 00:00
  • Patterns of Non-Adherence to Oral Antiviral Drugs

    May 1, 2018, 00:00
  • Economic Evaluation of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma

    May 1, 2018, 00:00
  • Patient Access to Medicines for Rare Diseases in European Countries

    May 1, 2018, 00:00
  • Three-Part Pricing to Reward Pharmaceutical Innovation and Increase Access- Case of PCSK9 Inhibitors

    May 1, 2018, 00:00
  • Impact of Skeletal-Related Events on Anti-Tumor Therapy Pattern in Patients with Bone Metastases from Prostate Cancer

    May 1, 2018, 00:00
  • Cost-Effectiveness of Regular Utilization of Zoledronic Acid for Developed Bone Metastases from Advanced Lung Cancer in Chinese Patients

    May 1, 2018, 00:00
  • Prescription Drugs Prices and Source of Payments in The US from 1997 to 2015

    May 1, 2018, 00:00
  • Analysis of Minimization of Costs of Equivalent Therapeutic Alternatives (ATE) in a General Hospital of Belo Horizonte / Mg, Brazil

    May 1, 2018, 00:00
  • Long-Term Effectiveness of a Gambling Intervention Program Among Children in Central Illinois

    May 1, 2018, 00:00
  • Costs of Hepatitis C- How Much Does it Cost Not to Treat a Patient with Hepatitis C

    May 1, 2018, 00:00
  • Direct Costs Associated with Multiple Myeloma Model Patient in 2017 From Single EU Jurisdiction

    May 1, 2018, 00:00
  • Implementation of Piecewise Structural Equation Modelling (SEM) as an Alternative to Traditional Sem- A Simulation Study

    May 1, 2018, 00:00
  • Extending Inferences from Randomized Participants to All Eligible Individuals Using Clinical Trials Nested Within Cohorts

    May 1, 2018, 00:00
  • Reduced Risk of Hyperprolactinemia Among Patients Treated With Atypical Antipsychotics That Are Associated with Low or No Prolactin Elevation

    May 1, 2018, 00:00
  • Hospital Lenght of Stay and Costs In Patients with Urinary Track Infections- Analysis of US National In-Patient Data for 2015 Using ICD-9 and ICD-10 Diagnoses

    May 1, 2018, 00:00
  • Geographic Variation of High-Risk Opioid Use and Risk of Overdose Among Disabled Medicare Beneficiaries in the US from 2011 to 2015

    May 1, 2018, 00:00
  • Association Between Bleeding Events and Health-Related Quality-of-Life in Adults with Severe Hamophilia A

    May 1, 2018, 00:00
  • Development and Psychometric Testing of the Adherence Promotion Activities Scale for Pharmacist-Initiated HIV Patient Care in Ambulatory Settings

    May 1, 2018, 00:00
  • «
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58 (current)
  • 59
  • 60
  • »